$ABBV earnings: how the stock has historically moved next day
How ABBV has reacted before
| Report | Next-day move |
|---|---|
| Jul 2026 | -0.7% |
| Apr 2026 | +3.1% |
| Feb 2026 | -3.8% |
| Oct 2025 | -4.5% |
| Apr 2025 | +3.2% |
| Jan 2025 | +4.7% |
Median absolute move 3.5% · higher 3 of 6 · n=6
AbbVie Inc. reports Q2 adjusted EPS of $3.65, raises revenue outlook as Rinvoq and Skyrizi drive robust growth and pipeline advancements signal future potential.
How $ABBV has reacted to earnings
| Report | Next-day |
|---|---|
| Jul 2026 | -0.7% |
| Apr 2026 | +3.1% |
| Feb 2026 | -3.8% |
| Oct 2025 | -4.5% |
| Apr 2025 | +3.2% |
| Jan 2025 | +4.7% |
Base rate (n=6):
- Median absolute next-day move: 3.5%
- Higher next day: 3 of 6
- Biggest up day: +4.7%
- Biggest down day: -4.5%